InterventionsHuman trial

Time to Reach Weight Reduction Thresholds with Tirzepatide vs. Semaglutide—A Post Hoc Analysis of SURMOUNT-5

ADA Scientific Sessions 2025 Abstract

The paper

Deborah Bade Horn, Louis J. Aronne, Julia P. Dunn,

Hunter T. Hoffmann, Beverly L. Falcón, Dachuang Cao,

Clare Lee

Houston

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 2202-LB

doi.org/10.2337/db25-2202-lb

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026